Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Purple Biotech Ltd ADR (PPBT)

Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Purple Biotech Ltd ADR 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 ISR

www.purple-biotech.com Employees: 9 P: 972-3933-3121 F: 972-350-9719

Sector:

Medical

Description:

Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.

Key Statistics

Overview:

Market Capitalization, $K 6,243
Enterprise Value, $K -1,157
Shares Outstanding, K 1,285
Float, K 1,246
% Float 97.02%
Short Interest, K 77
Short Float 5.98%
Days to Cover 1.00
Short Volume Ratio 0.26
% of Insider Shareholders 2.98%
% of Institutional Shareholders 9.64%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -7,240 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,300 K
EBIT, $ 2,890 K
EBITDA, $ 3,080 K

Growth:

1-Year Return -83.76%
3-Year Return -98.85%
5-Year Return -99.51%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 91.68%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/14/25
Next Earnings Date 03/09/26 [--]
Earnings Per Share ttm -1.12
EPS Growth vs. Prev Qtr 27.50%
EPS Growth vs. Prev Year 80.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 03/02/26

PPBT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -9.97%
Return-on-Assets % -8.90%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.20
Book Value/Share 2.55
Interest Coverage -14.17
60-Month Beta 0.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar